IFF invests $30 M to expand regional footprint in Singapore

New innovation centre and Singapore Flexiblend plant to accelerate innovation and broaden co-creation capabilities in Greater Asia

IFF, an industry leader in food, beverage, health, biosciences, has announced the opening of its new Singapore Innovation Centre, the first in its global network of research, creative and application centres to integrate the technologies, capabilities and expertise of all four business divisions: Nourish, Health & Biosciences, Scent and Pharma Solutions. At nearly 11,000 square meters, it is IFF’s largest in the region.

Its launch, following IFF’s newly operational Singapore Flexiblend plant in Tuas, marks the latest in the company’s nearly $30 million investment into Singapore. The two sites are part of a series of aggressive investments IFF is making to accelerate innovation, broaden its co-creation capabilities, drive speed to market and enhance accessibility to customers across Asia.

Situated in Singapore’s premier biomedical research hub, the ultra-modern center features more than ten creation, design and analytical laboratories, a collaboration studio, and culinary and demo kitchens, providing customers with full sensory capabilities to support each stage of the process from ideation through commercialization.

The state-of-the-art Singapore Flexiblend plant which had its grand opening on Oct. 12, will increase supply robustness and provide customized biotechnology solutions catered to the grain processing and animal nutrition and health customers in the region.

Image credit- businesswire

Read Previous

Total economic opportunity for smart protein in 2030 ranges upto Rs 33,194 Cr: GFI Report

Read Next

Commercial factors driving unhealthy diets: Study

Leave a Reply